Search
Now showing items 1-1 of 1
Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
(Brac University, 2022-04)
A decade has passed since no new Alzheimer's disease (AD) therapies were approved, even
though it is the leading motive of dementia in the modern era. The community of patients with
AD leads to expansion. Anxiety, anger, ...